Publication Date:
2020
abstract:
Tegaserod (ZelnormĀ®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C).
Iris type:
1.1 Articolo in rivista
List of contributors:
Madia, Valentina Noemi; Messore, Antonella; Saccoliti, Francesco; Tudino, Valeria; De Leo, Alessandro; De Vita, Daniela; Bortolami, Martina; Scipione, Luigi; Pindinello, Ivano; Costi, Roberta; Di Santo, Roberto
Published in: